Sort
16,300 grants matching “fatty liver disease”
Molecular Biology, Bioinformatics and Biostatistics Core
$700,181Subhashinee Wijeratne · University Of Nebraska Lincoln · P20 · FY2014 · GM
Molecular Biology, Bioinformatics and Biostatistics Core
$700,181Subhashinee Wijeratne · University Of Nebraska Lincoln · P20 · FY2017 · GM
Molecular Biology, Bioinformatics and Biostatistics Core
$700,181Subhashinee Wijeratne · University Of Nebraska Lincoln · P20 · FY2016 · GM
In vivo HTS assay for novel modulators of Apolipoprotein B
$699,728Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2021 · DK
Metabolic Health during Puberty: the Healthy Start Study
$699,677Dana Dabelea · University Of Colorado Denver · R01 · FY2025 · DK
Metabolic Health during Puberty: the Healthy Start Study
$699,607Dana Dabelea · University Of Colorado Denver · R01 · FY2023 · DK
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
$699,515Rohit Loomba · University Of California, San Diego · U01 · FY2022 · AA
Metabolic Health during Puberty: the Healthy Start Study
$699,478Dana Dabelea · University Of Colorado Denver · R01 · FY2022 · DK
Genetic investigations of cardiometabolic disease: pleiotropy, gene x environment and causal inference analyses
$699,469Rany Salem · University Of California, San Diego · R01 · FY2025 · DK
Multi-omics study of ancestry enriched associations in Hispanics/Latinos
$699,000Nora Franceschini · Univ Of North Carolina Chapel Hill · R01 · FY2025 · HG
Obesity complicating type 1 diabetes in young people: Physiology and Impact of GLP-1 analogue anti-obesity treatment on cardiometabolic risk factors
$698,781Michelle Van Name · Yale University · R01 · FY2024 · DK
Confounder-Corrected Quantitative MRI Biomarkers of Hepatic
$698,355Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2014 · DK
Molecular Biophysics of Mitochondrial Membranes
$698,134Yuriy Kirichok · Washington University · R35 · FY2023 · GM
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$697,731Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$697,731Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH)
$697,594Lindsay Tara Fourman · Massachusetts General Hospital · R01 · FY2024 · AG
Adipose Mitochondial Quality Control and Cardiovascular Function in Metabolically Healthy and Unhealthy Obese Monkeys
$697,403Kylie Kavanagh · Wake Forest University Health Sciences · R01 · FY2019 · HL
Nutrient overload, insulin resistance, and hepatic mitochondrial dysfunction
$697,269Elizabeth Jane Parks · University Of Missouri-Columbia · R01 · FY2017 · DK
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$697,241David E Cohen · Brigham And Women'S Hospital · R01 · FY2023 · DK
Exploring the Fuel-Mediated Programming of Neonatal Growth
$697,101Dana Dabelea · University Of Colorado Denver · R01 · FY2014 · DK
Development of CB1 Monoclonal Antibodies for Treating NASH
$697,083Benjamin Jacob Doranz · Integral Molecular · R44 · FY2019 · DK
Neuroimaging predictors of bariatric surgical outcomes
$697,082Pavlos Papasavas · Hartford Hospital · R01 · FY2021 · DK
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)
$696,977D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Molecular Prognostic Indicators in Liver Cirrhosis and Cancer
$696,850Yujin Hoshida · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · DK
The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases
$696,646Arya Mani · Yale University · R01 · FY2023 · DK